TY - JOUR AU - Travert, Camille AU - Tomasini, Pascale AU - Jeanson, Arnaud AU - Greillier, Laurent AU - Barlesi, Fabrice PY - 2019 TI - First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer JF - Translational Cancer Research; Vol 8, No 7 (November 28, 2019): Translational Cancer Research Y2 - 2019 KW - N2 - In these past few years, immune checkpoint inhibitors (ICI) in locally advanced or metastatic non-small cell lung cancer (NSCLC) have fundamentally changed the prognosis for some patients. UR - https://tcr.amegroups.org/article/view/29228